> Details

Møller, Peter Loof; Rohde, Palle Duun; Dahl, Jonathan Nørtoft; Rasmussen, Laust Dupont; Nissen, Louise; Schmidt, Samuel Emil; McGilligan, Victoria; Gudbjartsson, Daniel F.; Stefansson, Kari; Holm, Hilma; Bentzon, Jacob Fog; Bøttcher, Morten; Winther, Simon; Nyegaard, Mette

Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease
  • Contributor: Møller, Peter Loof; Rohde, Palle Duun; Dahl, Jonathan Nørtoft; Rasmussen, Laust Dupont; Nissen, Louise; Schmidt, Samuel Emil; McGilligan, Victoria; Gudbjartsson, Daniel F.; Stefansson, Kari; Holm, Hilma; Bentzon, Jacob Fog; Bøttcher, Morten; Winther, Simon; Nyegaard, Mette
  • Published: Springer Science and Business Media LLC, 2024
  • Published in: Genome Medicine, 16 (2024) 1
  • Language: English
  • DOI: 10.1186/s13073-024-01313-8
  • ISSN: 1756-994X
  • Keywords: Genetics (clinical) ; Genetics ; Molecular Biology ; Molecular Medicine
  • Origination:
  • Footnote:
  • Description: Abstract Background The presence of coronary plaques with high-risk characteristics is strongly associated with adverse cardiac events beyond the identification of coronary stenosis. Testing by coronary computed tomography angiography (CCTA) enables the identification of high-risk plaques (HRP). Referral for CCTA is presently based on pre-test probability estimates including clinical risk factors (CRFs); however, proteomics and/or genetic information could potentially improve patient selection for CCTA and, hence, identification of HRP. We aimed to (1) identify proteomic and genetic features associated with HRP presence and (2) investigate the effect of combining CRFs, proteomics, and genetics to predict HRP presence. Methods Consecutive chest pain patients (n = 1462) undergoing CCTA to diagnose obstructive coronary artery disease (CAD) were included. Coronary plaques were assessed using a semi-automatic plaque analysis tool. Measurements of 368 circulating proteins were obtained with targeted Olink panels, and DNA genotyping was performed in all patients. Imputed genetic variants were used to compute a multi-trait multi-ancestry genome-wide polygenic score (GPSMult). HRP presence was defined as plaques with two or more high-risk characteristics (low attenuation, spotty calcification, positive remodeling, and napkin ring sign). Prediction of HRP presence was performed using the glmnet algorithm with repeated fivefold cross-validation, using CRFs, proteomics, and GPSMult as input features. Results HRPs were detected in 165 (11%) patients, and 15 input features were associated with HRP presence. Prediction of HRP presence based on CRFs yielded a mean area under the receiver operating curve (AUC) ± standard error of 73.2 ± 0.1, versus 69.0 ± 0.1 for proteomics and 60.1 ± 0.1 for GPSMult. Combining CRFs with GPSMult increased prediction accuracy (AUC 74.8 ± 0.1 (P = 0.004)), while the inclusion of proteomics provided no significant improvement to either the CRF (AUC 73.2 ± 0.1, P = 1.00) or the CRF + GPSMult (AUC 74.6 ± 0.1, P = 1.00) models, respectively. Conclusions In patients with suspected CAD, incorporating genetic data with either clinical or proteomic data improves the prediction of high-risk plaque presence. Trial registration https://clinicaltrials.gov/ct2/show/NCT02264717 (September 2014).
  • Access State: Open Access